Frank Holler, Chairman & CEO
Frank Holler is an active investor and successful entrepreneur. He previously served as President & CEO of Xenon Pharmaceuticals Inc.; President & CEO of ID Biomedical Corporation; and as a founding director of Angiotech Pharmaceuticals.
   
   
Ambrose Hong, Chief Financial Officer

Ambrose Hong has over 15 years of senior financial management and executive experience in organizations of varying sizes and in various industries including investment fund management, manufacturing, technology, and land development. Ambrose has extensive experience in accounting and finance functions, strategic transactions and compliance management.